EP3762026
USE OF PCSK9 INHIBITOR FOR REDUCING CARDIOVASCULAR RISK
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
6.3.2019EP published:
8.4.2026EP application number:
19715280.4
EPO information:
European Patent Register
Max expiry date:
5.3.2039Expiry date:
5.3.2027
Title in English:
USE OF PCSK9 INHIBITOR FOR REDUCING CARDIOVASCULAR RISKLanguage of the patent:
English
Timeline
Today
6.3.2019EP application
8.4.2026EP Publication
5.3.2027Expires
Owner
Name:
Sanofi BiotechnologyAddress:
54 rue La Boétie, 75008 Paris, FR
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
SCHWARTZ, GregoryAddress:
Denver, Colorado 80220, US
Name:
PORDY, RobertAddress:
New York 10591, US
Name:
BESSAC, LaurenceAddress:
75008 Paris, FR
Name:
HANOTIN, CorinneAddress:
75008 Paris, FR
Name:
SASIELA, WilliamAddress:
New York 10591, US
Name:
STEG, PhilippeAddress:
75008 Paris, FR
Priority
Number:
201862639407 PDate:
6.3.2018Country:
US
Number:
201862640361 PDate:
8.3.2018Country:
US
Number:
201862641082 PDate:
9.3.2018Country:
US
Number:
201862641918 PDate:
12.3.2018Country:
US
Number:
201862657495 PDate:
13.4.2018Country:
US
Number:
201862683695 PDate:
12.6.2018Country:
US
Number:
201862688622 PDate:
22.6.2018Country:
US
Number:
201862717530 PDate:
10.8.2018Country:
US
Number:
201862736284 PDate:
25.9.2018Country:
US
Number:
201862744008 PDate:
10.10.2018Country:
US
Number:
201862746319 PDate:
16.10.2018Country:
US
Number:
201862770530 PDate:
21.11.2018Country:
US
Number:
201862775219 PDate:
4.12.2018Country:
US
Number:
201962797680 PDate:
28.1.2019Country:
US
Number:
201962802545 PDate:
7.2.2019Country:
US
Number:
201962806313 PDate:
15.2.2019Country:
US
Number:
19305247Date:
4.3.2019Country:
EP
Classification
Categories:
C07K 16/40, A61K 39/00, G01N 33/92, A61P 9/00